Reslizumab
HS-3025
Approved small_molecule active
Quick answer
Reslizumab for Asthma is a Approved program (small_molecule) at Teva Pharma GmbH with 5 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Asthma
- Phase
- Approved
- Modality
- small_molecule
- Status
- active